Ontology highlight
ABSTRACT:
ORGANISM(S): Homo Sapiens (human)
SUBMITTER: Fuyuki Kametani
PROVIDER: PXD018434 | JPOST Repository | Thu Apr 09 00:00:00 BST 2020
REPOSITORIES: jPOST
Action | DRS | |||
---|---|---|---|---|
MSA-PTMs.xlsx | Xlsx | |||
MSA1-5PeptideList.xlsx | Xlsx | |||
MSA1-9633.raw | Raw | |||
MSA2-201804.raw | Raw | |||
MSA3-9665.raw | Raw |
Items per page: 5 1 - 5 of 9 |
Schweighauser Manuel M Shi Yang Y Tarutani Airi A Kametani Fuyuki F Murzin Alexey G AG Ghetti Bernardino B Matsubara Tomoyasu T Tomita Taisuke T Ando Takashi T Hasegawa Kazuko K Murayama Shigeo S Yoshida Mari M Hasegawa Masato M Scheres Sjors H W SHW Goedert Michel M
Nature 20200527 7825
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases<sup>1</sup>. Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and believed to be caused by the formation of, filamentous inclusions of α-synuclein in brain cells<sup>2,3</sup>. However, the structures of α-synuclein filaments from the human brain are unknown ...[more]